Amgen Inc. (BVMF:AMGN34)
58.51
-1.56 (-2.60%)
At close: Aug 1, 2025, 4:55 PM GMT-3
Arcadium Lithium Revenue
Amgen had revenue of $9.18B USD in the quarter ending June 30, 2025, with 9.43% growth. This brings the company's revenue in the last twelve months to $34.92B, up 12.88% year-over-year. In the year 2024, Amgen had annual revenue of $33.42B with 18.57% growth.
Revenue (ttm)
$34.92B
Revenue Growth
+12.88%
P/S Ratio
4.41
Revenue / Employee
$1.25M
Employees
28,000
Market Cap
838.42B
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.42B | 5.23B | 18.57% |
Dec 31, 2023 | 28.19B | 1.87B | 7.09% |
Dec 31, 2022 | 26.32B | 344.00M | 1.32% |
Dec 31, 2021 | 25.98B | 555.00M | 2.18% |
Dec 31, 2020 | 25.42B | 2.06B | 8.83% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Rede D'Or São Luiz | 51.35B |
Raia Drogasil | 39.81B |
Hypera | 6.70B |
Fleury | 7.80B |
Odontoprev | 2.46B |
Oncoclínicas do Brasil Serviços Médicos | 6.26B |
Empreendimentos Pague Menos | 13.68B |
Blau Farmacêutica | 1.77B |